Lista de obras -

"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.

artículo científico publicado en 2018

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.

artículo científico publicado en 2018

A nurse-initiated pain protocol in the ED improves pain treatment in patients with acute musculoskeletal pain

artículo científico publicado en 2016

ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.

artículo científico publicado en 2006

Assessment of the relation between initial culprit vessel patency in acute ST-elevation myocardial infarction and endothelial function

artículo científico publicado en 2014

Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial

artículo científico publicado en 2015

Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial.

artículo científico publicado en 2017

Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomiz

artículo científico publicado en 2015

Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial

artículo científico publicado en 2014

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT.

artículo científico publicado en 2017

Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): rationale and study design of the randomized TWENTE III multicenter trial.

artículo científico

Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcome

artículo científico publicado en 2014

Endothelial Dysfunction After ST-segment Elevation Myocardial Infarction and Long-term Outcome: A Study With Reactive Hyperemia Peripheral Artery Tonometry

artículo científico publicado en 2016

F9 Malmö, factor IX and deep vein thrombosis

artículo científico publicado en 2009

Fibrinolysis and the risk of venous and arterial thrombosis.

artículo científico publicado en 2007

Five-Year Outcome After Implantation of Zotarolimus- and Everolimus-Eluting Stents in Randomized Trial Participants and Nonenrolled Eligible Patients: A Secondary Analysis of a Randomized Clinical Trial

artículo científico

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registry

scientific article published on 13 August 2014

Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II).

artículo científico publicado en 2016

Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.

artículo científico publicado en 2006

Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents

artículo científico publicado en 2018

Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial

artículo científico publicado en 2016

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

artículo científico publicado en 2005

No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study

artículo científico publicado en 2007

Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From the DUTCH PEERS (TWENTE II) Randomized Trial

artículo científico publicado en 2016

Pain management in the emergency chain: the use and effectiveness of pain management in patients with acute musculoskeletal pain

artículo científico publicado en 2014

Painful Discrimination in the Emergency Department: Risk Factors for Underassessment of Patients' Pain by Nurses

artículo científico publicado en 2017

Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study

artículo científico publicado en 2015

Prediabetes and its Impact on Clinical Outcome After Coronary Intervention in a Broad Patient Population

artículo científico publicado en 2018

Prehospital paths and hospital arrival time of patients with acute coronary syndrome or stroke, a prospective observational study

artículo científico publicado en 2016

Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents: A Patient-Level Pooled Analysis of TWENTE I-III

artículo científico publicado en 2020

Results of a survey among GP practices on how they manage patient safety aspects related to point-of-care testing in every day practice

artículo científico publicado en 2015

Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations

artículo científico publicado en 2007

Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year follow-up: A systematic review and meta-analysis of studies

artículo científico publicado en 2016

Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial

artículo científico publicado en 2015

Serum lipid levels and the risk of venous thrombosis

artículo científico publicado en 2004

Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents: A Patient-Level Pooled Analysis From the TWENTE and DUTCH PEERS Trials

artículo científico publicado en 2016

Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial

artículo científico publicado en 2016

Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use.

artículo científico publicado en 2008

Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis

artículo científico publicado en 2008

TCT-19 Two-Year Clinical Outcome and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Non-Bifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

TCT-241 Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

TCT-570 3-Year Clinical Outcome of the DUTCH PEERS (TWENTE II) Randomized Trial: Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Versus Platinum-Chromium Everolimus-Eluting Promus Element Stents in All-Comer Patients

scholarly article by Clemens von Birgelen et al published October 2015 in Journal of the American College of Cardiology

The effect of flight-related behaviour on the risk of venous thrombosis after air travel

artículo científico publicado en 2008

The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction

artículo científico publicado en 2017

The impact of the fibrinolytic system on the risk of venous and arterial thrombosis.

artículo científico publicado en 2009

The relationship between exercise and risk of venous thrombosis in elderly people

artículo científico publicado en 2008

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT

scientific article published on 14 August 2019

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

scientific article published on 31 October 2013

Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial

artículo científico publicado en 2017

Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial

artículo científico publicado en 2014

Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.

artículo científico publicado en 2014

Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial

artículo científico publicado en 2016

Trauma team activation varies across Dutch emergency departments: a national survey

artículo científico publicado en 2015

Travel-related venous thrombosis: results from a large population-based case control study (MEGA study).

artículo científico publicado en 2006

Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS.

artículo científico publicado en 2016

Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial

artículo científico publicado en 2015

Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.

artículo científico publicado en 2016

Lista de obras de

"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.

A nurse-initiated pain protocol in the ED improves pain treatment in patients with acute musculoskeletal pain

ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.

Assessment of the relation between initial culprit vessel patency in acute ST-elevation myocardial infarction and endothelial function

Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial

Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial.

Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomiz

Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT.

Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): rationale and study design of the randomized TWENTE III multicenter trial.

Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcome

Endothelial Dysfunction After ST-segment Elevation Myocardial Infarction and Long-term Outcome: A Study With Reactive Hyperemia Peripheral Artery Tonometry

F9 Malmö, factor IX and deep vein thrombosis

Fibrinolysis and the risk of venous and arterial thrombosis.

Five-Year Outcome After Implantation of Zotarolimus- and Everolimus-Eluting Stents in Randomized Trial Participants and Nonenrolled Eligible Patients: A Secondary Analysis of a Randomized Clinical Trial

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registry

Impact of severe lesion calcification on clinical outcome of patients with stable angina, treated with newer generation permanent polymer-coated drug-eluting stents: A patient-level pooled analysis from TWENTE and DUTCH PEERS (TWENTE II).

Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.

Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents

Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study

Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From the DUTCH PEERS (TWENTE II) Randomized Trial

Pain management in the emergency chain: the use and effectiveness of pain management in patients with acute musculoskeletal pain

Painful Discrimination in the Emergency Department: Risk Factors for Underassessment of Patients' Pain by Nurses

Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study

Prediabetes and its Impact on Clinical Outcome After Coronary Intervention in a Broad Patient Population

Prehospital paths and hospital arrival time of patients with acute coronary syndrome or stroke, a prospective observational study

Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents: A Patient-Level Pooled Analysis of TWENTE I-III

Results of a survey among GP practices on how they manage patient safety aspects related to point-of-care testing in every day practice

Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations

Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year follow-up: A systematic review and meta-analysis of studies

Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial

Serum lipid levels and the risk of venous thrombosis

Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents: A Patient-Level Pooled Analysis From the TWENTE and DUTCH PEERS Trials

Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial

Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use.

Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis

TCT-19 Two-Year Clinical Outcome and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Non-Bifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

TCT-241 Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

TCT-570 3-Year Clinical Outcome of the DUTCH PEERS (TWENTE II) Randomized Trial: Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Versus Platinum-Chromium Everolimus-Eluting Promus Element Stents in All-Comer Patients

The effect of flight-related behaviour on the risk of venous thrombosis after air travel

The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction

The impact of the fibrinolytic system on the risk of venous and arterial thrombosis.

The relationship between exercise and risk of venous thrombosis in elderly people

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial

Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial

Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.

Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial

Trauma team activation varies across Dutch emergency departments: a national survey

Travel-related venous thrombosis: results from a large population-based case control study (MEGA study).

Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS.

Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial

Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.